Difference between revisions of "Cyberdyne HAL"
(media impact) |
(added ref) |
||
Line 62: | Line 62: | ||
The company lists a number media articles on their website.<ref>http://www.cyberdyne.jp/english/company/Media_list.html</ref> The following is a digest of some of the selected articles about the device: | The company lists a number media articles on their website.<ref>http://www.cyberdyne.jp/english/company/Media_list.html</ref> The following is a digest of some of the selected articles about the device: | ||
− | An article in the Nikkei Asian Review talks about the financial difficulties the company had in the fiscal year of 2015. According to the news piece, investors are reluctant to buy Cyberdyne's shares because it failed to show new plans on how to expand their business. The high R&D costs greatly limited the company's net gain in finances. The article further talks about the company plans to expand into Europe with the medical-grade version of the device and informs that despite this expansion, Cyberdyne was not met with greatly increased financial gain. | + | An article in the Nikkei Asian Review talks about the financial difficulties the company had in the fiscal year of 2015. According to the news piece, investors are reluctant to buy Cyberdyne's shares because it failed to show new plans on how to expand their business. The high R&D costs greatly limited the company's net gain in finances. The article further talks about the company plans to expand into Europe with the medical-grade version of the device and informs that despite this expansion, Cyberdyne was not met with greatly increased financial gain.<ref>http://asia.nikkei.com/Japan-Update/Japan-s-Cyberdyne-sees-US-as-path-to-profit?page=1</ref> |
+ | |||
+ | |||
== Public Policy == | == Public Policy == |
Revision as of 10:20, 16 May 2016
Hybrid Assistive Limb | |
---|---|
Category | Limb-mounted |
Developer | Cyberdyne [1] |
Announced | 1997 (prototype)[2] |
Released | Developers:
Consumers: (not released) |
Price | 2000 USD (monthly)[3] |
Operating system | (unknown) |
Sensors |
bio-electric signals [4] |
Weight | 12000 g (Lower-limb model, both legs)[4] |
Controls |
user's brain signals [5] |
Data available | Limited |
Risk factor | Low |
Standalone | |
http://www.cyberdyne.jp/english/ |
Cyberdyne Hybrid Assistive Limb, or HAL, is a powered, wearable exoskeleton designed to support and assist the muscles of the user. It is used to return the ability to move to persons who lost it due to spinal injury or a stroke. It can be used in mobility therapy and restoration, movement assistance for the elderly, and movement and strength enhancement for workers or incident response teams.
Contents
Main characteristics
Cyberdyne HAL is equipped with neurosignal sensors that pick up the neural signals from the user's spine and translate them into the movement of the motorized joints. The user is only required to think about moving their limbs. HAL is currently used in neuromuscular feedback therapy. There are also plans to develop a powered exoskeleton to enhance workers working with heavy weights,[6] or powered and protective exoskeleton for emergency and disaster responders.[7]
Purpose
Cyberdyne HAL is a powered exoskeleton used in mobility therapy and for movement and strength enhancement.
Company & People
The exoskeleton is developed by a Japanese company Cyberdyne Inc. The company was founded on 24 June 2004 and is headquartered in Tsukuba, Japan.[8]
- Professor Yoshiyuki Sankai - President and founder
- Fumiyuki Ichihashi, Shinji Uga, Hiroaki Kawamoto - Directors
Important Dates
April 2016 - Keio University joins Cyberdyne to develop treatments for spinal cord injuries that combine induced pluripotent stem cell therapy and Cyberdyne's exoskeleton therapy.[9]
Enhancement/Therapy/Treatment
Enhancement & Therapy - The exoskeleton can be used to restore the ability to walk in spinal cord injuries patients and it can be also used to enhance the strength of a healthy human beyond their natural capabilities.
Ethical & Health Issues
We recorded no ethical or health issues connected to this particular device.
For more general issues connected with smartglasses, please see the Body-worn Wearables synopsis.
Public & Media Impact and Presentation
The company lists a number media articles on their website.[10] The following is a digest of some of the selected articles about the device:
An article in the Nikkei Asian Review talks about the financial difficulties the company had in the fiscal year of 2015. According to the news piece, investors are reluctant to buy Cyberdyne's shares because it failed to show new plans on how to expand their business. The high R&D costs greatly limited the company's net gain in finances. The article further talks about the company plans to expand into Europe with the medical-grade version of the device and informs that despite this expansion, Cyberdyne was not met with greatly increased financial gain.[11]
Public Policy
There is no policy regarding this particular device. However, policies relevant to Body-worn Wearables may apply to this device too.
Related Technologies, Projects or Scientific Research
http://www.ncbi.nlm.nih.gov/pubmed/24704677
http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1545505
http://www.tandfonline.com/doi/abs/10.3109/17483107.2015.1129455
http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=5953292&tag=1
http://link.springer.com/chapter/10.1007/978-3-642-34546-3_36#page-1
References
- ↑ http://cyberdyne.jp/english/company/Recruit.html
- ↑ http://web-japan.org/nipponia/nipponia38/en/feature/feature02.html
- ↑ http://www.theaustralian.com.au/news/world/robots-to-the-rescue-as-an-aging-japan-looks-for-help/story-e6frg6so-1226494698495
- ↑ 4.0 4.1 http://www.cyberdyne.jp/english/products/LowerLimb_nonmedical.html
- ↑ http://www.ccr-deutschland.de/en/healthcare/
- ↑ http://www.ccr-deutschland.de/en/2015/07/09/ondersteuning-van-de-arbeid/
- ↑ http://www.cyberdyne.jp/english/products/supporting.html
- ↑ http://www.cyberdyne.jp/english/company/index.html
- ↑ http://asia.nikkei.com/Tech-Science/Tech/Robotic-suit-iPS-therapy-to-be-tried-in-spinal-cord-rehab
- ↑ http://www.cyberdyne.jp/english/company/Media_list.html
- ↑ http://asia.nikkei.com/Japan-Update/Japan-s-Cyberdyne-sees-US-as-path-to-profit?page=1